[Beta-adrenergic blockers].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects; D004347:Drug Interactions; D007172:Erectile Dysfunction / Q000139:chemically induced; D006321:Heart / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D008297:Male; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012995:Solubility; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D013566:Sympathomimetics / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D013566:Sympathomimetics
Beta-adrenergichni blokeri.